Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

NCT00237250 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
171
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis